# A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects

> **NCT01918735** · PHASE1 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 66 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Placebo
- **DRUG:** GWP42006

## Key facts

- **NCT ID:** NCT01918735
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01918735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01918735, "A Study of the Safety and Tolerability of GWP42006 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01918735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*